Skip to main content
. 2022 Oct 26;14(21):4496. doi: 10.3390/nu14214496

Table 3.

Distribution of the exposure variables by outcomes.

Exposure Variables Severe Stunting Stunting HAZ (Mean) @ NM @
Number of days IFA consumed *** *** *
None 12.69 31.81 −1.24 2.87
1–90 9.08 25.89 −1.07 2.26
90+ 7.36 21.99 −1.00 2.26
Two or more doses of SP/Fansidar *** *** *
No 9.78 27.60 −1.12 2.62
Yes 8.06 22.79 −0.99 2.07
Days IFA consumed + timing of ANC visit *** *** *
No iron/No ANC 12.62 31.52 −1.24 2.89
1st trimester_1 to 90 7.48 23.45 −1.00 2.41
1st trimester_90+ 6.21 20.11 −0.94 2.34
2nd trimester_1 to 90 9.23 26.59 −1.09 2.24
2nd trimester_90+ 8.45 23.75 −1.07 2.14
3rd trimester_1 to 90 11.52 27.82 −1.15 1.97
IFA + Malaria prophylaxis (IPTP2) *** *** *
No IFA, No IPTP2 13.03 32.50 −1.26 2.94
IFA 1–90, No IPTP2 9.39 27.34 −1.10 2.48
IFA 90+, No IPTP2 7.61 24.32 −1.07 2.41
No IFA, Only IPTP2 10.75 27.82 −1.11 2.42
IFA 1–90 & IPTP2 8.63 24.06 −1.02 2.01
IFA 90+ & IPTP2 7.24 20.92 −0.97 2.18

@ HAZ: Height–for–age Z–scores; NM: Neonatal mortality. p–value: * p < 0.05, *** p < 0.000.